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ABSTRACT
Objective:To assess the prevalence and potential risk factors associated with human papillomavirus
(HPV) cervical infection among women residing in a region of northeastern Argentina with a high
incidence of cervical cancer.
Methods: A case-control study of 330 women participating in a cervical cytological screening
program conducted in Posadas city, Misiones, Argentina, from February 1997 to November 1998
was carried out. Standardized questionnaires were administered, and clinical examination includ-
ing colposcopy was performed. Fresh endocervical specimens for HPV DNA detection by generic
polymerase chain reaction were collected and the products typed by dot-blot hybridization.
Results: Human papillomavirusDNA was found in 61% of samples analyzed (185/301). Samples
with normal cytology had a 43% infection rate (85/199), while those classified as low-grade squa-
mous intraepithelial lesion, high-grade squamous intraepithelial lesion, and invasive cervical car-
cinoma had an infection rate of96% (53/55), 100% (29/29), and 100% (18/18), respectively. Human
papillomavirus typing showed a 64% (118/185) prevalence of type 16 among all the infected popu-
lation analyzed; type 16 was detected among 49% (42/85) of infected samples with normal.cytology
and in an average of 74% (74/100) with abnormal cytology. Sexual behavior, residence in southern
Paraguay, and history of a previous sexually transmitted diseases were the main risk factors
associated with high-grade cervical lesions.
Conclusions:An elevated prevalence ofHPV infection was detected in this population, which also
has a high incidence of cervical cancer. The broad distribution of high-risk HPV type 16 in women
with normal cytology and colposcopy suggests that viral infection is an important determinant of
regional cancer incidence. Infect. Dis. Obstet. Gynecol. 7:237-243, 1999. (C) 1999 Wiley-Liss, Inc.
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ssociations between human papillomavirus
(HPV) and cervical neoplasia have been re-
ported consistently. International studies have
shown that cervical cancer is the second most com-
mon cause of cancer in women worldwide, with a
prevalence that varies (1-4 cases in 10,000 accord-
ing to the implementation of successful public
health programs for screening and treatment, z
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Different HPV types have been detected in
more than 95% of cases of invasive cervical cancer
(ICC) and in varying percentages in cases of low-
grade squamous intraepithelial lesion (LSIL) and
high-grade squamous intraepithelial lesion (HSIL).3-
Studies examining risk factors for HPV infection
have not been entirely consistent,9,1 probably due
to differences in the studied populations and the
detection methods used. It would be of importance
to focus on particular characteristics of the popula-
tion under study, such as demographic growth rate,
regional human displacement around the area un-
der analysis, and sexual habits, as well as overall
HPV prevalence and presence of specific HPV
types.
In Argentina, there are still no complete epide-
miologic data to state the actual, global situation
regarding HPV infection and its association with
cervical neoplasia. Nevertheless, regional studies
have shown that cervical cancer incidence varies
widely, with values that range from 1-3 cases per
10,000 women residing in metropolitan areas to 4
cases per 1,000 women in peripheral regions. 11
The Province of Misiones is situated at the
northeastern tip of Argentina and shares interna-
tional borders with Paraguay and Brazil. The con-
struction in the last ten years of bridges and road-
ways and the creation of a common market includ-
ing these three countries have promoted an intense
population migration along the entire territory.
This new situation has changed several cultural
habits.
Since the implementation of a program of cer-
vical cancer screening by cytology in 1995 in Mi-
siones, an elevated incidence of 3-4 cases of ICC
per 1,000 women has been reported consistently,
together with high incidences of LSIL (16 per
1,000) and HSIL (11 per 1,000).
These values have defined an area of high can-
cer incidence where some particular factors prob-
ably are involved, lz,13 The aim of this study was to
assess the HPV prevalence and potential risk fac-
tors associated with viral cervical infection among
women from this region.
SUBJECTS AND METHODS
Study Population
Three hundred and thirty women were recruited
from 5,676 participants attending either the Cen-
tral Regional Hospital, two family practice clinics
in Posadas, (Misiones, Argentina) or a clinic in En-
carnacion (Paraguay) as part of an ongoing cervical
cancer screening program from February 1997 to
November 1998.
A written informed consent form was signed by
all participants, and a standardized, self-administered
questionnaire concerning sociodemographic fac-
tors, sexual and reproductive history, use of birth
control, and history of other sexually transmitted
diseases was completed. All women underwent a
standard gynecologic examination and colposcopy,
during which material for Papanicolaou smears was
collected with cytobrush. To minimize the bias in
sample collection and to ensure a sufficient amount
of exfoliated cells, sampling was performed only if
the last menstruation had occurred at least one
week before the exam. The Pap test diagnosis was
used to classify subjects as controls (normal changes)
or cases (LSIL, HSIL, or ICC).4
The case group included all tested women with
abnormal cytology and/or abnormal colposcopy
ranging from LSIL to ICC. Fifty nine participants
were diagnosed with LSIL, 33 with HSIL, and 18
with ICC (all of the squamous cell type).
For each case, two population-based controls
were selected and matched for age of subject and
time when the sample was collected. This control
group included 220 women with normal colposcopy
and cytology and no history of sexually transmitted
diseases or HPV lesions. For the case-control trios
above 65 years old, an age difference of 5 years was
tolerated for matching purposes.
Biopsies were taken from abnormal areas and
under direct colposcopic vision when necessary.
Histopathologic examination was carried out, and
the final diagnosis was based on the worst morpho-
logic picture.
Human Papillomavirus DNA Analysis
Human papillomavirus detection samples were ob-
tained from the ecto- and endocervix using cyto-
brush and processed the same day of collection.
Cytobrushes were washed with sterile phosphate-
buffered saline solution, pH 7.4, and collected cells
lysed adding 200 pg/mL of proteinase K in the
presence of 0.5% SDS in a total reaction volume of
500 pL of cellular suspension and incubated for
hour at 55C. Nucleic acid was extracted as de-
scribed previously.5 Isolated DNA were tested by
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polymerase chain reaction (PCR) for betaglobin
gene to confirm the presence of an adequate and
amplifiable template in the samples. 16
The DNA was amplified with the general con-
sensus primers GP5+ and GP6+, targeting a region
of approximately 140 base pairs in the highly con-
served L10RF of the HPV viral genome. 17 DNA
from CaSki and HeLa cells were used as positive
controls; negative controls included no template
DNA and were included after each tenth specimen
in all tests.
The PCR reactions were carried out in 50 pL of
solution containing 10 pL of template DNA, 10
mM Tris HC1 (pH 8.3), 50 mM KC1, 3 mM MgC12,
100 pM dATP, dCTP, dTTP and dGTP, 10 pmol
of each primer, and 2 U of AmpliTaqTM (5 U/pL;
Perkin Elmer, New Jersey). A hot start technique
was used; the thermal cycling conditions were 94C
for 3 minutes, followed by 40 cycles at 93C for 30
second, 45C for 30 seconds, and 72C for 30 sec-
onds.
The amplification products were analyzed on
1.5% agarose gels, visualized with ethidium bro-
mide staining and ultraviolet light exposure, and
photographed. A single band of approximately 140
base pairs indicated a positive sample.
Dot-Blot Hybridization
Thirty-microliter aliquots resulting from positive
HPV generic PCR were denatured with 20 pL of
IN NaOH and dot-blotted to ZetaTM probe mem-
branes (BioRad, California). Positive and negative
controls were included in each assay. Biotin-
labeled oligonucleotides type-specific probes for
HPV types 6, 11, 16, and 18 were used. 18 Hybrid-
ization was performed at 55C for 3 hours. Filters
were washed twice for 10 minutes at 56C for HPV
types 6 and 11 and at 58C for HPV types 16 and
18. Positive hybridization dots were developed by
chemoluminescence (PhotoGeneTM nucleic acid
detection system, BRL, Grand Island, NY). Speci-
mens that showed a band of approximately 140
base pairs by ethidium bromide visualization but
that could not be typed with the type-specific
probes were referred to as "other HPV."
Statistical Analysis
The association between risk factors and the pres-
ence of HPV or lesion grade was assessed by uni-
variate analysis, 19 yielding estimates of the odds
TABLE I. General characteristics of the
study population
Characteristic Cases Controls
Median age (range, 17-69 y) 34 y 32 y
Median age at first intercourse
(range, 14-25 y) 18 y 20 y
Median age at first pregnancy
(range, 16-36 y) 23 y 22 y
Lifetime no. of sex partners
24% 28%
2-5 47% 45%
>5 29% 27%
History of sexually transmitted
diseases
Yes 21% 0%*
No 79% 100%*
Use of oral contraceptives
Yes 49% 36%**
No 35% 53%**
Other forms 16% I%
Marital status
Married 58% 60%
Single 30% 32%
Widow/divorced 12% 8%
Place of permanent residence
Northeastern Argentina 68% 65%
Southern Paraguay 32% 35%
Frequency of displacement
between countries
Once a week or less 6 I% 56%
Twice a week or more 39% 44%
Socioeconomic status
Upper/middle class 62% 59%
Low income 38% 4 I%
Education
Completed high school 64% 68%
Did not complete high school 36% 32%
*Significant difference (P < 0.001).
**Significant difference (P < 0.005).
ratio (OR); 95% confidence intervals (CI) gauged
the precision of the OR estimates. These analyses
were carried out using the Epi Info program (Cen-
ters for Disease Control, Atlanta, GA).
RESULTS
The general characteristics of the study population
at entry are summarized in Table 1. Interviews
were successfully completed for 330 subjects dur-
ing the accrual period. The cervical specimens
from 11 subjects were not evaluable because of
problems in transport or material quality. An addi-
tional set of 18 specimens failed to be amplified for
betaglobin. The present analysis refers to the re-
maining 301 evaluable participants, 199 with nor-
mal cytology (control group); 55 with LSIL, 29 with
HSIL, and 18 with ICC (cases group).
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TABLE 2. Odds ratio associating HPV infection with
abnormal cytology
Controls Cases
No. subjects No. subjects
(%) (%) OR (95% CI)
HPV (-) 114 (57) 2 (I.9) 1.0
HPV (+) 85 (43) 100 (98.1) 67 (39.3-74.5)
Total 199 102
The median age was 33 years old, with an age
range from 17 to 69 years. There were 33 subjects
(11%) who were under 20 years old; 58 (19.3%)
were 20-29 years old, 113 (37.5%) were 30-39 years
old, 55 (18.3%) were 40-49, 23 (7.6%) were 50-60
years old, and 19 (6.3%) were over age 60 years.
Human papillomavirus DNA was found in 61%
of samples analyzed (185/301). In the control
group, 43% (85/199) of samples were positive for
HPV, while those with LSIL, HSIL, or ICC were
HPV positive in 96% (53/55), 100% (29/29), and
100% (18/18) of cases, respectively. Table 2 shows
the strong association of HPV infection (crude OR,
67) with abnormal cytology.
HPV typing results are presented in Table 3.
Infections with two viral types were detected in 17
women (20%) from the cases group; eight with
LSIL cytology (15%) and nine with HSIL (31%).
Among the LSIL cases with mixed infections, five
had HPV types 11 and 16, and three had HPV
types 16 and 18. In those with HSIL cytology, five
samples showed HPV 6 and 16, two showed HPV
11 and 16, and two showed HPV 16 and 18.
The most prevalent type was HPV 16, which
was detected in 49% (42/85) of infected samples
from the control group (overall prevalence, 21%), in
77% of those with LSIL, in 72% of those with
HSIL, and in 67% of those with ICC.
The association of HPV-16 infection and abnor-
mal cytology is presented in Table 4. The associa-
tion between selected variables (potential risk fac-
tors) of the cases group and abnormal cytology is
presented in Table 5. Early age at first sexual in-
tercourse, multiple lifetime number of sex part-
ners, early age of first pregnancy, residence in
southern Paraguay, and history of previous sexually
transmitted diseases correlated significantly to
HSIL and ICC lesions.
Univariate analysis of the same variables in
HPV-positive subjects who were in the control
group is shown in Table 6. Strong associations are
TABLE 3. Prevalence of HPV DNA in controls
and cases
Overall HPV type-specific
HPV positivity (%)
No. positivity
subjects (%) 6 16 18 Other
199 controls 43 7.5 2.0 21.1 3.0 9.0
55 LSIL 96 5.7 17.0 77.3 13.2 1.9
29 HSIL 100 27.6 13.8 72.4 13.8 3.5
18 ICC 100 0 0 66.6 17.4 16.0
Viral types other than 6, II, 16, or 18.
bType-specific percentages include multiple types infections.
cSquamous-cell type carcinoma.
TABLE 4. Association of HPV type 16 infection with
abnormal cytology
HPV 16
prevalence (%) OR (95% CI)
Controls infected
85 21.1
Cases (no. and type)
53 LSIL 77.3
29 HSIL 72.4
18 ICC 66.6
12.7 (4.7-35. I)
9.6 (3.6-30.4)
7.4 (2.1-28.6)
Any HPV type.
found between HPV infection and multiple life-
time number of sex partners and early age at first
sexual intercourse; there are weaker correlations
with frequency of displacement between Posadas
(Argentina) and Encarnacion (Paraguay), use of oral
contraceptives, and low socioeconomic status.
DISCUSSION
Cervical carcinoma is the leading cause of death by
cancer in women in the Province of Misiones, Ar-
gentina, with an elevated incidence of 3 cases per
1,000. This value is particularly high compared
with other regions of the country (1 case in 10,000
on average) where data are available. This situation
prompted us to conduct a case-control study to in-
vestigate HPV infection in the female population
as a condition necessary but not sufficient for pro-
gression to cervical neoplasia3-8 and to analyze
some regional factors probably associated with it.
The study group was representative of the regional
population and was characterized by married,
middle-class, well-educated women.
In the analysis of HPV DNA present in cervical
samples from the control group, we found an el-
evated percentage of viral infection (43%), showing
predominantly HPV type 16. As the role of certain
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TABLE 5. Association of abnormal cytology with selected variables in the cases group
LSIL HSIL ICC
Variable n 53 (%) OR (95% CI) n 29 (%) OR (95% CI) n 18 (%) OR (95% CI)
Age at first intercourse (y)
22-25
18-21
14-17
Lifetime no. of sex partners
2-5
>5
Age at first pregnancy (y)
30-36
21-29
16-20
Place of permanent residence
Northeastern Argentina
Southern Paraguay
History of sexually transmitted
diseases
No
Yes
Use of oral contraceptives
No
Yes
Socioeconomic status
Upper/middle class
Low income
8 (34.0%)
21 (39.6%)
4 (26.4%)
2 (22.6%)
22 (41.5%)
9 (35.9%)
4 (26.4%)
21 (39.6%)
8 (34.0%)
1.0 5 (I 7.2%) 1.0 2 (I I. I%) 1.0
1.3 (0.7-2.6) II (37.9%) 2.9 (I .9-4.3) 6 (33.3%) 4.0 (2.7-6. I)
0.7 (0.5-I. I) 13 (44.9%) 3.9 (2.5-5.6) 10 (55.6%) 6.2 (4.6-10.8)
1.0 5 (I 7.2%) 1.0 3 (I 6.6%) 1.0
2.4 (I .2-3.4) 13 (44.8%) 3.9 (2.5-5.2) 8 (44.4%) 4.0 (2.4-6. I)
1.9 (0.9-2.5) II (38.0%) 2.9 (I.8-4.5) 7 (39.0%) 3.2 (2.1-4.9)
1.0 6 (20. I%) 1.0 3 (I 6.6%) 1.0
1.8 (I .3-3. I) 9 (31.0%) 1.7 (I .2-3.0) 7 (38.9%) 3.2 (2.5-5. I)
1.5 (I. I-2.7) 14 (48.9%) 3.6 (2.7-5.4) 8 (44.5%) 4.0 (2.9-5.9)
29 (54.7%) 1.0 10 (34.5%) 1.0 6 (33.3%) 1.0
24 (45.3%) 0.8 (0.6-1.2) 19 (65.5%) 3.6 (2.6-5. I) 12 (66.7%) 4.0 (2.8-6.0)
37 (69.8%) 1.0 II (37.9%) 1.0 7 (38.8%) 1.0
16 (30.2%) 0.4 (0.2-0.7) 18 (62. I%) 2.7 (I .5-3.6) (61.2%) 2.5 (I .7-3.9)
24 (45.3%) 1.0 (37.9%) 1.0 (61. I%) 1.0
29 (54.7%) 1.5 (0.3-2.5) 18 (62. I%) 2.7 (I .9-3.5) 7 (38.9%) 0.5 (0.3-1.0)
32 (60.4%) 1.0 13 (44.8%) 1.0 7 (38.9%) 1.0
21 (39.6%) 0.7 (0.5-1.1) 16 (55.2%) 1.5 (0.8-2.1) II (61.1%) 2.5 (I.4-3.6)
HPV types (16, 18, 31, 33, and 45) in cervical car-
cinogenesis becomes indisputable, the detection of
these HPV types in cervical samples is being con-
sidered in conjunction with cytologyz to improve
diagnostic accuracy and efficiency.
A comparatively high level of HPV generic in-
fection and HPV 16 prevalence values in cytologi-
cally normal women have been reported by Kjaer
et al. in a population-based study done in Green-
land.1 Similar studies carried out in areas with a
high incidence of cervical cancer in South America,
such as Recife, Brazil,8 and Colombia,zl have re-
ported lower total HPV infection prevalences (13%
and 9%, respectively).
Cervical HPV infection detected by PCR tech-
nique is found in 5-50% of asymptomatic women
of reproductive age presenting for Pap test screen-
ing in different countries. When additional cervi-
cal specimens are taken from these women in fol-
low-up surveys, the majority of the infections are
found to be transient, and only a small proportion
of women tend to harbor the same HPV type in
subsequent samples,zz Prospective epidemiological
studies suggest that only persistent infection with
high-risk HPV types of the cervical epithelium trig-
ger tumor development,z However, knowing that
cervical cancer poses an important problem in this
region, our data showing a high prevalence of HPV
types 16 and 18 in healthy women are of significant
value and should be considered in public health
policy program implementation.
Univariate risk factors analysis of the control
group yielded strong associations between HPV in-
fection and sexual behavior (lifetime number of
sexual partners and early age at first intercourse),
and a weak but interesting association with low
socioeconomic status and the frequency of dis-
placement between Argentina and Paraguay.
The overall HPV infection prevalences for our
cases group agrees with previous studies carried out
worldwide, showing an increasing viral detection
rate associated with the severity of lesions. In this
study, the prevalence of HPV general infection in
abnormal cytology coincides with that found by van
den Brule et al.,z3 Cromme et al.,z4 and de Roda
Husman et al.z5 in the Netherlands, who applied
the same PCR approach.
In all degree of lesions, HPV types 16 predomi-
nated significantly. The LSIL samples showed a
high prevalence of HPV 16 (77.3%) compared with
other studies done worldwide (45-55% range of
prevalence). The high HPV 16 prevalence in
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TABLE 6. Association of HPV infection with risk factors in the control group
No. of HPV
Variable subjects positive (%) OR (95% CI)
Lifetime no. of sex partners
51 11.8
2-5 93 5O.5
>5 55 58.2
Age at first intercourse (y)
22-25 60 20.0
18-21 83 45.8
14-17 56 62.5
Frequency of displacement
between countries
Once a week or less 105 31.4
Twice a week or more 94 55.3
Use of oral contraceptives
No 102 31.3
Yes 97 54.6
Socioeconomic status
Upper/middle class II 8 33.9
Low income 81 55.5
Placement of permanent residence
Northeastern Argentina 129 38.0
Southern Paraguay 70 51.4
Age at first pregnancy (y)
30-36 42 42.8
21-29 74 39.2
16-20 83 45.8
1.0
7.7 (4.2-15.6)
10.4 (5.3-19.2)
1.0
3.4 (2.0-5.6)
6.6 (3.4-9.7)
1.0
2.7 (I .5-5.2)
1.0
2.6 (I .3-4.8)
1.0
2.4 (.-4.3)
1.0
1.7 (0.8-3. I)
I.O
0.9 (0.3-1.7)
I.I (0.6-1.9)
HSIL (72.4%) is only comparable with that found
by Sebbelov et al. in a study of a population at high
risk for cancer in Greenland.z6
All ICC samples were HPV positive but 16% of
them were infected with viral types other than
HPV 6, 11, 16, or 18, suggesting that other carci-
nogenic types may be involved.
Sexual behavior was associated with progression
of high-degree lesions in infected subjects; perma-
nent residence in Paraguay was also strongly asso-
ciated with HSIL and ICC, probably due to the
absence of regular Pap test screening programs in
that country.
The elevated proportion of women infected
with carcinogenic viral types and normal cytology is
an important finding that must be considered as a
relevant challenge. A follow-up study of this sub-
clinical group may provide important data regard-
ing regional characteristics ofHPV genital infection
and natural history of cervical cancer precursor le-
sions. Several particular characteristics of this re-
gional population have been associated with either
HPV infection (frequency of subject displacement
between Argentina and Paraguay) or lesion severity
(place of permanent residence). Implementing co-
ordinated public health policies between Argentina
and Paraguay, such as a simultaneous Pap test
screening program in borderline cities, may help in
lowering cervical cancer cases.
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